S. Kulkarni

发表

High‐grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis

D. Catovsky, A. Wotherspoon, E. Matutes, 2008, British journal of haematology.

Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study

G. Morgan, B. Sirohi, G. Cook, 2007, Bone Marrow Transplantation.

Does donor–recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?

S. Singhal, J. Mehta, D. Tait, 2002, Bone Marrow Transplantation.

Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation.

S. Singhal, J. Mehta, R. Powles, 1998, Blood.

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?

S. Singhal, J. Mehta, D. Tait, 2000, Bone Marrow Transplantation.

Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies

M. Dennis, T. Somervaille, J. Cavet, 2013, South Asian Journal of Cancer.

Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants.

S. Singhal, J. Mehta, B. Sirohi, 2000, Blood.

Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)

S. Singhal, J. Mehta, D. Tait, 1999, Bone Marrow Transplantation.

Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients

S. Singhal, J. Mehta, R. Powles, 1997, Bone Marrow Transplantation.

Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease

S. Singhal, J. Mehta, B. Sirohi, 2003, Bone Marrow Transplantation.

Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

S. Singhal, J. Mehta, M. Gore, 1997, Bone Marrow Transplantation.

An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of interferon-alpha2b.

G. Morgan, A. Leary, B. Sirohi, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma

J. Mehta, T. Powles, S. Ashley, 2000, British Journal of Cancer.

Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center

J. Radford, T. Illidge, K. Linton, 2013, Haematologica.

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

S. Singhal, J. Mehta, H. Pandha, 2000, Bone Marrow Transplantation.

Gonadal function following ABVD therapy for Hodgkin's disease.

P. Parikh, S. Advani, S. Kulkarni, 1997, American journal of clinical oncology.

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

S. Singhal, J. Mehta, D. Tait, 2000, The Lancet.

Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission

S. Singhal, J. Mehta, B. Sirohi, 2003, Bone Marrow Transplantation.

Rapid cytoreduction in childhood leukemic hyperleukocytosis by conservative therapy.

S. Pai, P. Kurkure, C. Nair, 1995, Medical and pediatric oncology.

Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma.

S. Singhal, J. Mehta, N. Raje, 1997, British Journal of Cancer.

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma

S. Singhal, J. Mehta, B. Sirohi, 2002, Bone Marrow Transplantation.

Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling.

S. Singhal, J. Mehta, R. Powles, 1999, Leukemia & lymphoma.

Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria

S. Singhal, J. Mehta, B. Sirohi, 2001, Bone Marrow Transplantation.

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C‐VAMP) as induction treatment followed by autografting in previously untreated myeloma

S. Singhal, J. Mehta, D. Cunningham, 1997, British journal of haematology.

Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system

S. Singhal, J. Mehta, N. Raje, 1999, British journal of haematology.